Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.65
Low: 0.65
Prev. Close: 0.65
KZG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exclusive Tantalum Off-Take Agreement

7 Sep 2021 07:00

RNS Number : 8883K
Kazera Global PLC
07 September 2021
 

Kazera Global plc

Exclusive Tantalum Off-Take Agreement

Kazera Global plc, the AIM quoted investment company, is pleased to report that, following the conclusion of its plan to commence Tantalum production at its mine in Tantalite Valley, as announced on 1 September 2021, it has now entered into an Off-Take Agreement for the sale of all Tantalum produced by it.

 

· 3-year contract, through to 31 December 2024, entered with Jiujiang Jinxin Nonferrous Metals Co Ltd at Tantalite Valley

· A test sample assay has already been approved by the customer and airfreighted to China for factory testing

· Interest expressed in developing the Company's Lithium deposit

Utilizing Kazera Global's CEO, Larry Johnson's former long career in Tantalum supply chains, the Company entered into negotiations with several potential end users of Tantalum. After extensive due diligence, Jiujiang Jinxin Nonferrous Metals Co Ltd based in Jiangxi Province, China, was selected as the Company's preferred purchaser. Jinxin specializes in various product lines related to Tantalum, Niobium and their derived products, which include High-purity Tantalum Pentoxide, High-purity Niobium Pentoxide, Common Grade Tantalum Pentoxide, Common Grade Niobium Pentoxide and K2TaF7 (Ksalt). Jinxin ′s products are sold throughout China as well as to America, Japan, Korea and European countries. Jinxin have entered into a three-year initial contract to purchase all Tantalum concentrate produced by Kazera at a fixed price that is competitive in terms of those paid globally by end-users of Tantalum.

A test sample has already been successfully assayed in Namibia and has now been airfreighted to Jinxin for factory testing. Payment for this sample is expected by the Company during September 2021.

Jinxin has also expressed an interest in becoming involved in the Company's development of its Lithium deposit.

Larry Johnson, Kazera Joint Chief Executive Officer, commented: 

"We chose to enter into an agreement with Jinxin because they clearly understand the complexities of plant operational restarts and can utilise the high grade of Tantalite. I have also had extensive positive experience of working with them in the past. Sourcing product from Namibia has major advantages for buyers as the country is far removed from conflict and has excellent infrastructure. We were approached by dealers in Tantalum who would have accepted much lower standards, but who we felt have less growth, flexibility and commitment than displayed by Jinxin."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR').

For further information on the Company, visit: www.kazeraglobal.com

 

Kazera Global plc (c/o Camarco)

Larry Johnson/Dennis Edmonds (Joint CEO's)

Tel: +44 (0)203 757 4980

 

finnCap (Nominated Adviser and Joint Broker)

Christopher Raggett / Charlie Beeson (corporate finance)

 

Tel: +44 (0)207 220 0500

 

Camarco (PR)

Gordon Poole / James Crothers / Hugo Liddy

 

 

  Tel: +44 (0)20 3781 8331

 

**ENDS**

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREQLFBFKLLBBV
Date   Source Headline
1st Jul 20107:00 amRNSFinal Results
22nd Apr 20107:00 amRNSDirector/PDMR Shareholding
15th Apr 20101:55 pmRNSAcquisition and Trading Update
26th Jan 20103:40 pmRNSDirector/PDMR Shareholding
25th Jan 20102:07 pmRNSDirectorate Change
18th Dec 20094:28 pmRNSHolding(s) in Company
17th Dec 20092:24 pmRNSHolding(s) in Company
15th Dec 20097:00 amRNSAcquisition
4th Dec 20093:07 pmRNSReplacement: Director/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding
1st Dec 20097:00 amRNSInterim Results
1st Dec 20097:00 amRNSAcquisition
22nd Sep 200912:28 pmRNSAnnual Financial Report
29th Jul 200912:14 pmRNSAnnual General Meeting
16th Jun 20097:00 amRNSPreliminary Results
3rd Mar 20093:50 pmRNSHolding(s) in Company
3rd Mar 20092:40 pmRNSHolding(s) in Company
2nd Mar 20095:11 pmRNSHolding(s) in Company
2nd Mar 20094:00 pmRNSHolding(s) in Company
2nd Mar 20098:05 amRNSDirector/PDMR Shareholding
26th Feb 20092:02 pmRNSResult of General Meeting
10th Feb 20094:35 pmRNSPrice Monitoring Extension
10th Feb 20097:00 amRNSIssue of Equity
19th Nov 20087:01 amRNSInterim Results
29th Oct 20087:01 amRNSTrading Statement
10th Oct 20084:52 pmRNSSecond Price Monitoring Extn
10th Oct 20084:41 pmRNSPrice Monitoring Extension
7th Oct 20089:39 amRNSHolding(s) in Company
25th Sep 20089:52 amRNSAnnual Report and Accounts
10th Sep 20085:36 pmRNSHolding(s) in Company
1st Sep 20087:30 amRNSDirectorate Change
18th Aug 20083:00 pmRNSDisposal of investment proper
30th Jul 20082:39 pmRNSDirector/PDMR Shareholding
30th Jul 200810:59 amRNSQ1 Update and Result of EGM
10th Jul 200811:45 amRNSDirector/PDMR Shareholding
8th Jul 20089:17 amRNSNotice of EGM
30th Jun 20083:02 pmRNSDirectorate Change
19th Jun 20087:00 amRNSPreliminary Results
29th Apr 20084:54 pmRNSChange of registered address
15th Apr 20082:06 pmRNSWebsite Address
14th Apr 20084:00 pmRNSChange of name effective
14th Apr 20082:03 pmRNSResult of AGM/Change of name
7th Apr 20082:54 pmRNSDirector/PDMR Shareholding
7th Apr 200812:45 pmRNSDirector/PDMR Shareholding
12th Mar 20088:00 amRNSDirector/PDMR Shareholding
11th Mar 200811:37 amRNSDirector/PDMR Shareholding
11th Mar 20087:02 amRNSFinal Results
1st Feb 200812:14 pmRNSHolding(s) in Company
1st Feb 20087:00 amRNSTrading Statement
16th Jan 200812:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.